Venus Remedies Limited VENUSREM.NS Stock
Venus Remedies Limited Price Chart
Venus Remedies Limited VENUSREM.NS Financial and Trading Overview
Venus Remedies Limited stock price | 330 INR |
Previous Close | 237.5 INR |
Open | 238.35 INR |
Bid | 246 INR x 0 |
Ask | 246.45 INR x 0 |
Day's Range | 238.2 - 252.7 INR |
52 Week Range | 127.85 - 264 INR |
Volume | 88.57K INR |
Avg. Volume | 73.61K INR |
Market Cap | 3.3B INR |
Beta (5Y Monthly) | 1.07226 |
PE Ratio (TTM) | 12.399397 |
EPS (TTM) | 21.73 INR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | September 23, 2013 |
1y Target Est | N/A |
VENUSREM.NS Valuation Measures
Enterprise Value | 2.83B INR |
Trailing P/E | 12.399397 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.5831999 |
Price/Book (mrq) | 0.7161243 |
Enterprise Value/Revenue | 0.5 |
Enterprise Value/EBITDA | 4.011 |
Trading Information
Venus Remedies Limited Stock Price History
Beta (5Y Monthly) | 1.07226 |
52-Week Change | 14.70% |
S&P500 52-Week Change | 20.43% |
52 Week High | 264 INR |
52 Week Low | 127.85 INR |
50-Day Moving Average | 201.26 INR |
200-Day Moving Average | 188.88 INR |
VENUSREM.NS Share Statistics
Avg. Volume (3 month) | 73.61K INR |
Avg. Daily Volume (10-Days) | 83.07K INR |
Shares Outstanding | 13.37M |
Float | 6.06M |
Short Ratio | N/A |
% Held by Insiders | 45.80% |
% Held by Institutions | 0.0010% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 4.69% |
Operating Margin (ttm) | 6.75% |
Gross Margin | 41.50% |
EBITDA Margin | 12.46% |
Management Effectiveness
Return on Assets (ttm) | 4.04% |
Return on Equity (ttm) | 5.89% |
Income Statement
Revenue (ttm) | 5.66B INR |
Revenue Per Share (ttm) | 423.36 INR |
Quarterly Revenue Growth (yoy) | 16.50% |
Gross Profit (ttm) | 2.35B INR |
EBITDA | 705.2M INR |
Net Income Avi to Common (ttm) | 265.7M INR |
Diluted EPS (ttm) | 19.88 |
Quarterly Earnings Growth (yoy) | 4642.69% |
Balance Sheet
Total Cash (mrq) | 738.5M INR |
Total Cash Per Share (mrq) | 55.22 INR |
Total Debt (mrq) | 422.9M INR |
Total Debt/Equity (mrq) | 9.19 INR |
Current Ratio (mrq) | 3.911 |
Book Value Per Share (mrq) | 344.214 |
Cash Flow Statement
Operating Cash Flow (ttm) | 366.2M INR |
Levered Free Cash Flow (ttm) | 242.48M INR |
Profile of Venus Remedies Limited
Country | India |
State | N/A |
City | Panchkula |
Address | Plot 51-52, Industrial Area |
ZIP | 134113 |
Phone | 91 17 2393 3090 |
Website | https://www.venusremedies.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Venus Remedies Limited develops and markets pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, anticoagulant, cardiac, disinfectant and antiseptic, gastro therapy, hand sanitizers, hormones, iron supplements, neurology, oncology, pain management, respiratory, skin and wound care, stress reliever, urology, and vitamins/minerals/nutrients, as well as antimicrobial resistance products. It also provides disinfectants; and a portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula, India.
Q&A For Venus Remedies Limited Stock
What is a current VENUSREM.NS stock price?
Venus Remedies Limited VENUSREM.NS stock price today per share is 330 INR.
How to purchase Venus Remedies Limited stock?
You can buy VENUSREM.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Venus Remedies Limited?
The stock symbol or ticker of Venus Remedies Limited is VENUSREM.NS.
Which industry does the Venus Remedies Limited company belong to?
The Venus Remedies Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Venus Remedies Limited have in circulation?
The max supply of Venus Remedies Limited shares is 13.37M.
What is Venus Remedies Limited Price to Earnings Ratio (PE Ratio)?
Venus Remedies Limited PE Ratio is 15.18637850 now.
What was Venus Remedies Limited earnings per share over the trailing 12 months (TTM)?
Venus Remedies Limited EPS is 21.73 INR over the trailing 12 months.
Which sector does the Venus Remedies Limited company belong to?
The Venus Remedies Limited sector is Healthcare.